Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FITMI - First In Treating Male Infertility
2021-003451-42Phase 2Terminated
- Sponsor
- Department of Growth and Reproduction
- Start
- Jun 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of denosumab in male infertility, sponsored by Department of Growth and Reproduction. Primary endpoint: Sperm concentration. Started Jun 2021; status: terminated.
02
Drugs
denosumab
03
Conditions
male infertility
Beyond the preview
Go deeper on 2021-003451-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003451-42.